Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.31 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL11043959 | 0.78 | TSHR (0.44) | DPP4 | |
| SCHEMBL10897289 | 0.78 | — | — | |
| SCHEMBL109553 | 0.78 | — | — | |
| Propionic Acid SCHEMBL28712841 | 0.75 | FFAR3 (0.50) | FFAR3DPP4 | |
| SCHEMBL2561091 | 0.74 | DPP4 (0.39) | DPP4CTSKDRD3 | |
| Propionic Acid SCHEMBL357729 | 0.74 | FFAR3 (0.56) | FFAR3GRIN2DGRIN1GRIN2AGRIN2B | |
| Propionic Acid SCHEMBL27484067 | 0.72 | — | — | |
| Propionic Acid SCHEMBL28449386 | 0.72 | FFAR3 (0.71) | FFAR3 | |
| Propionic Acid SCHEMBL27407991 | 0.72 | FFAR3 (0.53) | FFAR3GRIN2DGRIN1GRIN2AGRIN2B | |
| Propionic Acid SCHEMBL1577186 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9815001-B2 | Use of a fiber conduit contactor for extraction | Chemtor, LP. (US) | 2017-11-14 | — | — | US | disclosed |
| US-20170014733-A1 | Use Of A Fiber Conduit Contactor For Extraction | MASSINGILL, DR. JOHN | 2017-01-19 | — | — | US | disclosed |
| US-9468866-B2 | Use of a fiber conduit contactor for metal and/or metalloid extraction | CHEMTOR, LP (US) | 2016-10-18 | — | — | US | disclosed |
| WO-2014047195-A1 | USE OF A FIBER CONDUIT CONTACTOR FOR METAL AND/OR METALLOID EXTRACTION | CHEMTOR, LP (US) | 2014-03-27 | — | — | WO | disclosed |
| US-20140076805-A1 | Use of a Fiber Conduit Contactor for Metal and/or Metalloid Extraction | CHEMTOR, LP (US) | 2014-03-20 | — | — | US | disclosed |
| CN-102199442-B | Method for applying amine proton-type ionic liquid extractant in desulfurization of oil product and recovering extractant | UNIV DALIAN | 2013-11-06 | — | — | CN | disclosed |
| CN-102199442-A | Method for applying amine proton-type ionic liquid extractant in desulfurization of oil product and recovering extractant | UNIV DALIAN | 2011-09-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170014733-A1 | Use Of A Fiber Conduit Contactor For Extraction | SORD, NEFM, FGF2 | FFAR3 1428/4885DPP4 946/4885CTSK 3507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.